Company / Net Income
BioRestorative Therapies, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$14.2M
FY2025
5-year range
-$44.3M / -$10.4M
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$10M to -$14M over the past 2 years.
Based on SEC 10-K filings.
-$14M in FY2025.
Declined from -$10M to -$14M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 36.7% year-over-year.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$14.2M | -36.7% |
| FY2024 | -$10.4M | +0.0% |
| FY2023 | -$10.4M | +43.7% |
| FY2022 | -$18.5M | +58.3% |
| FY2021 | -$44.3M | -202.5% |
| FY2020 | -$14.6M | -17.0% |
| FY2019 | -$12.5M | -32.5% |
| FY2018 | -$9.4M | -9.4% |
| FY2017 | -$8.6M | -9.0% |
| FY2016 | -$7.9M | -41.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026